no mgmt doesnt to short term traders but it does have an obligation from a risk perspective for all shareholders - short medium and long. This deal structure is 100% backing themselves in. The only thing sure about bio trials is they are never 100%.... especially in the neuro space. That's where I think the mistake is made with the deal structure. Its ok to want to preserve company value long term but I think there has to be a derisking event prior (via upfront).
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren and ACADIA announce agreement for North America
Ann: Neuren and ACADIA announce agreement for North America, page-428
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8 | $18.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 3429 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 18.000 |
2 | 582 | 17.950 |
2 | 650 | 17.500 |
1 | 100 | 17.150 |
2 | 3116 | 17.100 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 3429 | 4 |
15.400 | 15 | 1 |
15.500 | 2500 | 1 |
15.800 | 1425 | 1 |
16.000 | 7061 | 2 |
Last trade - 16.16pm 08/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable